Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS)

INR 43.14

(1.03%)

Operating Income Summary of Biofil Chemicals and Pharmaceuticals Limited

  • Biofil Chemicals and Pharmaceuticals Limited's latest annual operating income in 2023 was 20.65 Million INR , down -49.98% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited's latest quarterly operating income in 2024 Q1 was 2.09 Million INR , up 635.73% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported an annual operating income of 8.34 Million INR in 2022, down -19.37% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported an annual operating income of 10.34 Million INR in 2021, down -47.3% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported a quarterly operating income of -1.1 Million INR for 2023 Q4, down -197.0% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported a quarterly operating income of 4.17 Million INR for 2023 FY, down -49.98% from previous quarter.

Annual Operating Income Chart of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2007)

Historical Annual Operating Income of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2007)

Year Operating Income Operating Income Growth
2023 20.65 Million INR -49.98%
2022 8.34 Million INR -19.37%
2021 10.34 Million INR -47.3%
2020 19.62 Million INR 25.43%
2019 15.64 Million INR 112.28%
2018 7.37 Million INR 15.24%
2017 6.39 Million INR -73.4%
2016 24.05 Million INR 297.09%
2015 6.05 Million INR -35.08%
2014 9.32 Million INR 16.84%
2013 7.98 Million INR -7.26%
2012 8.6 Million INR 252.86%
2011 2.43 Million INR -75.61%
2010 10 Million INR 82.56%
2009 5.48 Million INR 320.11%
2008 -2.49 Million INR 34.99%
2007 -3.83 Million INR 0.0%

Peer Operating Income Comparison of Biofil Chemicals and Pharmaceuticals Limited

Name Operating Income Operating Income Difference
Alembic Pharmaceuticals Limited 5.75 Billion INR 99.641%
Hester Biosciences Limited 364.77 Million INR 94.337%
Aarti Drugs Limited 7.14 Billion INR 99.711%
Aarti Pharmalabs Limited 3.12 Billion INR 99.34%
Albert David Limited 1.33 Billion INR 98.452%
Alembic Limited 767.77 Million INR 97.31%
Alkem Laboratories Limited 19.46 Billion INR 99.894%
Bafna Pharmaceuticals Limited 237.66 Million INR 91.309%
Bajaj HealthCare Limited - INR -Infinity%
Brooks Laboratories Limited -72.25 Million INR 128.589%
Eris Lifesciences Limited 5.18 Billion INR 99.601%
FDC Limited 3.03 Billion INR 99.319%
Glenmark Life Sciences Limited 8.97 Billion INR 99.77%
Gufic Biosciences Limited 2.89 Billion INR 99.286%
Hikal Limited 1.49 Billion INR 98.618%
Ind-Swift Limited 1.22 Billion INR 98.315%
Innova Captab Limited 2.53 Billion INR 99.185%
IOL Chemicals and Pharmaceuticals Limited 4.94 Billion INR 99.582%
Jagsonpal Pharmaceuticals Limited 214.04 Million INR 90.349%
Jubilant Pharmova Limited 5.18 Billion INR 99.602%
Lincoln Pharmaceuticals Limited 1.9 Billion INR 98.916%
Lupin Limited 27.75 Billion INR 99.926%
Mangalam Drugs & Organics Limited 27.45 Million INR 24.772%
Medico Remedies Limited 277.11 Million INR 92.546%
Morepen Laboratories Limited 4.17 Billion INR 99.505%
Nectar Lifesciences Limited 3.89 Billion INR 99.469%
Orchid Pharma Limited 2.36 Billion INR 99.125%
Procter & Gamble Health Limited 2.78 Billion INR 99.259%
RPG Life Sciences Limited 2.29 Billion INR 99.099%
Kilitch Drugs (India) Limited 208.05 Million INR 90.072%
Sigachi Industries Limited 1.47 Billion INR 98.599%
Solara Active Pharma Sciences Limited -3.85 Billion INR 100.536%
Suven Pharmaceuticals Limited 4.6 Billion INR 99.552%
Themis Medicare Limited 1.3 Billion INR 98.415%
Unichem Laboratories Limited - INR -Infinity%
Vaishali Pharma Limited 6.29 Million INR -228.186%
Wanbury Limited 1.7 Billion INR 98.79%
Windlas Biotech Limited 1.29 Billion INR 98.41%
ZIM Laboratories Limited 1.09 Billion INR 98.119%
Ind-Swift Laboratories Limited 2 Billion INR 98.972%
Ipca Laboratories Limited 29.59 Billion INR 99.93%
Sun Pharmaceutical Industries Limited 104.3 Billion INR 99.98%
Venus Remedies Limited 534.65 Million INR 96.137%
Sakar Healthcare Limited 495.5 Million INR 95.831%
Aurobindo Pharma Limited 104.5 Billion INR 99.98%
Divi's Laboratories Limited 18.31 Billion INR 99.887%
AstraZeneca Pharma India Limited 4.47 Billion INR 99.538%
Mankind Pharma Limited 40.86 Billion INR 99.949%
Sequent Scientific Limited - INR -Infinity%
Laurus Labs Limited 3.94 Billion INR 99.477%
Neuland Laboratories Limited 5.31 Billion INR 99.612%
J. B. Chemicals & Pharmaceuticals Limited 7.54 Billion INR 99.726%
Glenmark Pharmaceuticals Limited 6.5 Billion INR 99.682%
Zydus Lifesciences Limited 45.39 Billion INR 99.954%
Amrutanjan Health Care Limited 621.02 Million INR 96.674%
Wockhardt Limited 140 Million INR 85.246%
Bal Pharma Limited 214.56 Million INR 90.373%
Dr. Reddy's Laboratories Limited 67.72 Billion INR 99.97%
Bliss GVS Pharma Limited 1.23 Billion INR 98.322%
Par Drugs and Chemicals Limited 551.58 Million INR 96.255%
Caplin Point Laboratories Limited 7.22 Billion INR 99.714%
Shilpa Medicare Limited 3.76 Billion INR 99.451%
Valiant Laboratories Limited - INR -Infinity%
Ajanta Pharma Limited 19.67 Billion INR 99.895%
Aarey Drugs & Pharmaceuticals Limited 2.83 Million INR -629.681%
Granules India Limited 6.52 Billion INR 99.684%
Medicamen Biotech Limited - INR -Infinity%
Syncom Formulations (India) Limited 249.25 Million INR 91.713%
Piramal Enterprises Limited - INR -Infinity%
Torrent Pharmaceuticals Limited 25.33 Billion INR 99.918%
NATCO Pharma Limited 25.96 Billion INR 99.92%
Suven Life Sciences Limited -1.22 Billion INR 101.685%
Krebs Biochemicals & Industries Limited - INR -Infinity%
Strides Pharma Science Limited 5.22 Billion INR 99.605%
Indoco Remedies Limited 1.52 Billion INR 98.645%
Alpa Laboratories Limited 61.51 Million INR 66.421%
Lasa Supergenerics Limited -458 Million INR 104.51%
Sun Pharma Advanced Research Company Limited -4.11 Billion INR 100.502%